Neutrophil-mediated ADCC toward cancer cells can be enhanced after neutrophil-activation, e.g., by granulocyte-colony stimulating factor (G-CSF) and interferon-γ (IFNγ) (32). This evidence concerns the gene CSF3 and cancer.